Cite
Gervais F, Jiang Y, Largeron N, et al. Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection. Value Health. 2014;17(7):A637doi: 10.1016/j.jval.2014.08.2288.
Gervais, F., Jiang, Y., Largeron, N., & Nikoglou, T. (2014). Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A637. https://doi.org/10.1016/j.jval.2014.08.2288
Gervais, F, et al. "Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A637. doi: https://doi.org/10.1016/j.jval.2014.08.2288
Gervais F, Jiang Y, Largeron N, Nikoglou T. Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection. Value Health. 2014 Nov;17(7):A637. doi: 10.1016/j.jval.2014.08.2288. Epub 2014 Oct 26. PMID: 27202273.
Copy
Download .nbib
